SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,811 | -50.3% | 30,593 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $146,540 | +7.6% | 30,593 | +27.4% | 0.00% | 0.0% |
Q1 2023 | $136,137 | +40.7% | 24,010 | +39.0% | 0.00% | 0.0% |
Q4 2022 | $96,746 | +42.3% | 17,276 | +61.9% | 0.00% | – |
Q3 2022 | $68,000 | +83.8% | 10,668 | 0.0% | 0.00% | – |
Q2 2022 | $37,000 | -51.3% | 10,668 | 0.0% | 0.00% | – |
Q1 2022 | $76,000 | +33.3% | 10,668 | +54.8% | 0.00% | – |
Q4 2021 | $57,000 | +18.8% | 6,893 | 0.0% | 0.00% | – |
Q3 2021 | $48,000 | -70.7% | 6,893 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $164,000 | -7.9% | 6,893 | -20.3% | 0.00% | 0.0% |
Q1 2021 | $178,000 | -16.0% | 8,650 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $212,000 | +2928.6% | 8,650 | +699.4% | 0.00% | – |
Q1 2019 | $7,000 | +40.0% | 1,082 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -37.5% | 1,082 | 0.0% | 0.00% | – |
Q3 2018 | $8,000 | -11.1% | 1,082 | 0.0% | 0.00% | – |
Q2 2018 | $9,000 | +12.5% | 1,082 | 0.0% | 0.00% | – |
Q1 2018 | $8,000 | -27.3% | 1,082 | 0.0% | 0.00% | – |
Q4 2017 | $11,000 | -35.3% | 1,082 | 0.0% | 0.00% | – |
Q3 2017 | $17,000 | +41.7% | 1,082 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | 0.0% | 1,082 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | +9.1% | 1,082 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | – | 1,082 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |